You just read:

Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX® Platform Technology

News provided by

Aridis Pharmaceuticals, Inc.

Jul 30, 2019, 05:30 ET